2-year Caries Clinical Study: Arginine Fluoride-Free Toothpastes vs. NaF Toothpaste
Launched by COLGATE PALMOLIVE · Sep 27, 2022
Trial Information
Current as of May 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed Consent Form signed by parent or legal guardian to permit participation of their child in the study
- • Willingness and ability to use the assigned products according to instructions, availability for all appointments and likelihood of completing the clinical trial.
- • Children ages 10-14 years at baseline.
- • Presence of second molars or evidence of erupting permanent molars.
- • Subjects should be of good general health as evidenced by a review of the medical history.
- • Presence of two or more active caries lesions (ICDAS scores of 2 or greater) and with a previous caries experience (DMFS ≥ 2). Exclusion Characteristics
- * Subjects presenting with any of the criteria below will be excluded from the study:
- • Presence of fixed or removable prosthetic appliance or orthodontic treatment involving more than four permanent teeth.
- • Use of medication that could increase the risk of developing dental caries, i.e. medication that reduces saliva flow.
- • Long-term antibiotic therapy.
- • Children with cognitive and/or motor impairment.
- • Severe malocclusion.
- • Presence of severe caries (ICDAS 5 or 6) on five or more teeth.
- • Evidence of moderate to severe periodontal disease.
- • Participation in any other clinical study within the 30 days preceding the clinical study.
- • History of allergies or other adverse reactions to arginine, or oral care products, or their ingredients.
- • Pregnant or lactating.
About Colgate Palmolive
Colgate-Palmolive is a global leader in oral care, personal care, home care, and pet nutrition, dedicated to enhancing the health and well-being of consumers worldwide. With a strong commitment to innovation and sustainability, the company conducts clinical trials to advance its product offerings, ensuring safety and efficacy while adhering to the highest ethical standards. Colgate-Palmolive's rigorous research initiatives are designed to generate scientific evidence that supports the development of effective solutions, ultimately promoting healthier lifestyles and contributing to the betterment of communities globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, Shaanxi, China
Chengdu, Sichuan, China
Chongqing, , China
Patients applied
Trial Officials
Yun Po E Zhang, PhD, DDS(Hons)
Study Director
Colgate Palmolive
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials